查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區基因測序市場（按產品、最終用戶和國家分類）分析與預測（2024-2033 年）
市場調查報告書
商品編碼
1643948

亞太地區基因測序市場（按產品、最終用戶和國家分類）分析與預測（2024-2033 年）

Asia-Pacific Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 72 Pages | 商品交期: 1-5個工作天內

價格

預計2024年亞太地區基因測序市場規模將達13億美元。

預計 2024 年至 2033 年期間市場複合年成長率為 18.44%，2033 年達到 59.6 億美元。科學家可以透過確定生物體的整個 DNA 序列來破解生物體的整個基因組成，這個過程稱為基因序列測定。此步驟對於發現基因變異並了解其對健康和疾病的可能影響是必要的。由於使用次世代定序(NGS) 技術的產前和新生兒篩檢計畫的需求不斷增加、基因檢測的採用率不斷提高以及定序成本下降，亞太地區的基因測序市場正在快速成長。

不斷擴大的市場是長讀定序應用日益廣泛的結果，它能夠為複雜的遺傳資料提供更準確、更詳細的洞察。此外，亞太地區各地的政府計畫和投資正在加速基因測序技術的採用，改善醫療和科學應用的可近性。

主要市場統計數據
預測期 2024-2033
2024 年評估 13億美元
2033 年預測 59.6億美元
複合年成長率 18.44％

隨著該地區繼續優先考慮醫療保健進步和精準醫療，基因測序正在成為增強診斷、個人化治療和疾病預防的重要工具。這些因素預計將推動創新、增加消費者的獲取途徑並塑造亞太地區基因測序市場的未來。

由於測序技術的進步、價格的下降以及研究和醫療保健行業對基因檢測的需求不斷增加，亞太地區基因測序市場正在迅速擴張。基因定序是精準醫療的關鍵組成部分，它可以揭示生物體的整個 DNA 序列，有助於更好地預防疾病、制定個人化治療方案和增強診斷。

市場擴張的主要驅動力之一是次世代定序（NGS）在癌症診斷、罕見疾病識別以及產前和新生兒篩檢的應用日益廣泛。長讀定序技術可以讓人們詳細了解複雜的遺傳資料，該技術在該領域也變得越來越普遍。

為了加速定序技術的推廣，亞太地區各國政府正大力投資基因組研究和醫療保健基礎設施。這些項目以及教育機構和私人公司之間的合作提高了可近性和創新性。

本報告研究了亞太地區的基因測序市場，並提供了市場概況、產品、最終用戶和國家趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章基因測序市場：產業分析

  • 主要趨勢：當前和未來的影響評估
  • 監管分析
  • 價值和供應鏈分析

第2章基因測序市場：市場動態

  • 影響分析
  • 市場促進因素
  • 市場限制
  • 市場機會

第3章基因測序市場：未來展望

  • 專利分析
  • 競爭性基準化分析
  • 臨床實施順序
  • 未來展望

第4章基因測序市場（按地區）

  • 區域概況
  • 促進因素與限制因素
  • 亞太地區
    • 區域概況
    • 市場促進因素
    • 市場限制
    • 按產品
    • 按最終用戶
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他

基準化分析5基因測序。

  • 關鍵策略和發展
    • 夥伴關係、合作和業務擴展
    • 監管和法律活動
    • 新服務
    • 合併和收購
    • 資金籌措活動
  • 公司簡介
    • MGI Tech Co., Ltd.

第6章調查方法

Product Code: BHP2488SS

Introduction to Asia-Pacific Genome Sequencing Market

The Asia-Pacific genome sequencing market was valued at $1.30 billion in 2024 and is expected to reach $5.96 billion by 2033, growing at a CAGR of 18.44% between 2024 and 2033. Scientists can decipher an organism's entire genetic composition by determining its entire DNA sequence, a process known as genome sequencing. Finding genetic variations and comprehending their possible effects on health and illness require this procedure. Due to rising demand for prenatal and neonatal screening programs using next-generation sequencing (NGS) technologies, growing adoption of genetic testing, and falling sequencing costs, the genome sequencing market in Asia-Pacific is growing quickly.

The market is growing as a result of long-read sequencing's growing applications, which offer more precise and in-depth insights into complicated genetic data. Furthermore, government programs and investments throughout Asia-Pacific are speeding up the adoption of genome sequencing technologies and improving accessibility for medical and scientific applications.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$1.30 Billion
2033 Forecast$5.96 Billion
CAGR18.44%

As the area continues to prioritize healthcare advancements, and precision medicine, genome sequencing is emerging as a vital tool for enhancing diagnostics, personalized treatments, and disease prevention. These factors are expected to drive innovation and expand consumer access, shaping the future of the genome sequencing market in APAC.

Market Introduction

The market for APAC genome sequencing is expanding quickly due to improvements in sequencing technology, falling prices, and an increase in the need for genetic testing in the research and healthcare industries. A key component of precision medicine, genome sequencing reveals an organism's entire DNA sequence, facilitating better disease prevention, individualized treatment plans, and enhanced diagnostics.

One of the main factors propelling market expansion is the growing use of next-generation sequencing (NGS) in cancer diagnostics, rare disease identification, and prenatal and neonatal screening. Technologies for long-read sequencing, which offer in-depth understanding of intricate genetic data, are also becoming more popular in the area.

To hasten the adoption of sequencing technologies, governments throughout Asia-Pacific are making significant investments in genomic research and healthcare infrastructure. These programs, along with partnerships among educational institutions and private companies, are enhancing accessibility and innovation.

As the region prioritizes advancements in healthcare and precision medicine, the APAC genome sequencing market is poised for sustained growth, transforming medical research and improving patient outcomes.

Market Segmentation

Segmentation 1: by Product

  • Kits
  • Instruments
  • Software

Segmentation 2: by End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Population Sequencing Organizations
  • Research and Academic Institutes
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, funding, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the Asia-Pacific genome sequencing market.

Competitive Strategy: The Asia-Pacific genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the Asia-Pacific genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Genome Sequencing Market: Industry Analysis

  • 1.1 Key Trends: Current and Future Impact Assessment
    • 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
    • 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
  • 1.2 Regulatory Analysis
  • 1.3 Value and Supply Chain Analysis

2 Genome Sequencing Market: Market Dynamics

  • 2.1 Impact Analysis
  • 2.2 Market Drivers
    • 2.2.1 Decreasing Cost of Genome Sequencing Enabling High Usage of Genome Sequencing/Testing
    • 2.2.2 Rising Prenatal and New-Born Screening Programs Facilitating the Demand for Next-Generation Sequencing
    • 2.2.3 Expanding Applications of Long-Read Sequencing
    • 2.2.4 Government Investments and Initiatives in Genome Sequencing Projects
  • 2.3 Market Restraints
    • 2.3.1 Data Management Challenges in Genome Sequencing
    • 2.3.2 Genomic Data Disparity in Developing Countries
  • 2.4 Market Opportunities
    • 2.4.1 Emergence of Portable Genome Sequencing Enabling Bedside Testing
    • 2.4.2 Multiomics Shaping the Global Genome Sequencing Landscape

3 Genome Sequencing Market: Future Outlook

  • 3.1 Patent Analysis
    • 3.1.1 Patent Analysis (by Year)
    • 3.1.2 Patent Analysis (by Country)
  • 3.2 Competitive Benchmarking
    • 3.2.1 Market Share
    • 3.2.2 Brand Recognition
  • 3.3 Sequencing Clinical Adoption
  • 3.4 Future Outlook

4 Genome sequencing market (By Region)

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 By Product
    • 4.3.5 By End User
    • 4.3.6 China
      • 4.3.6.1 By Product
    • 4.3.7 Japan
      • 4.3.7.1 By Product
    • 4.3.8 India
      • 4.3.8.1 By Product
    • 4.3.9 Australia
      • 4.3.9.1 By Product
    • 4.3.10 South Korea
      • 4.3.10.1 By Product
    • 4.3.11 Rest-of-Asia-Pacific
      • 4.3.11.1 By Product

5 Genome sequencing market - Competitive Benchmarking and Company Profiles

  • 5.1 Key Strategies and Development
    • 5.1.1 Partnerships, Alliances, and Business Expansions
    • 5.1.2 Regulatory and Legal Activities
    • 5.1.3 New Offerings
    • 5.1.4 Mergers and Acquisitions
    • 5.1.5 Funding Activities
  • 5.2 Company Profiles
    • 5.2.1 MGI Tech Co., Ltd.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products and Services
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Key Personnel
      • 5.2.1.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation

List of Figures

  • Figure 1: Asia-Pacific Genome Sequencing Market, $Billion, 2024, 2028, and 2033
  • Figure 2: Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
  • Figure 4: Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
  • Figure 5: Key Players' Strategic Priorities
  • Figure 6: Potential Future Directions
  • Figure 7: Companies Utilizing Artificial Intelligence in Genomics
  • Figure 8: Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
  • Figure 9: Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
  • Figure 10: Value and Supply Chain Analysis, Genome Sequencing Market
  • Figure 11: Impact Analysis of Market Dynamics, 2022-2033
  • Figure 12: Genome Sequencing Cost Over Time, 2007-2024
  • Figure 13: Newborn Screening Program of Some of the Countries
  • Figure 14: Some Aspects of Long-Read Sequencing
  • Figure 15: Some of the Genome Sequencing Initiatives
  • Figure 16: Volume of Different Genetic Tests, Size in Base Pairs (bp)
  • Figure 17: Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
  • Figure 18: Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
  • Figure 19: Genome Sequencing Market, Market Share, 2023
  • Figure 20: Clinical Utility of Genome Sequencing
  • Figure 21: Future Outlook for Genome Sequencing
  • Figure 22: China Genome Sequencing Market, $Billion, 2023-2033
  • Figure 23: Japan Genome Sequencing Market, $Billion, 2023-2033
  • Figure 24: Australia Genome Sequencing Market, 2022-2033
  • Figure 25: South Korea Genome Sequencing Market, $Billion, 2023-2033
  • Figure 26: Rest-of-Asia-Pacific Genome Sequencing Market, $Billion, 2023-2033
  • Figure 27: Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
  • Figure 28: Regulatory and Legal Activities, January 2020-April 2024
  • Figure 29: New Offerings, January 2020-April 2024
  • Figure 30: Mergers and Acquisitions, January 2020-April 2024
  • Figure 31: Funding Activities, January 2020-April 2024
  • Figure 32: Data Triangulation
  • Figure 33: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Genome Sequencing Market, Market Opportunities
  • Table 3: Current and Future Impact of Trends
  • Table 4: Regulatory Landscape (by Country)
  • Table 5: Output and Approximate Required Disk Space to Store an Instrument Run
  • Table 6: Comparison of Some of the Key Sequencers
  • Table 7: Genome sequencing market (by Region), $Billion, 2023-2033
  • Table 8: Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 9: Asia-Pacific Genome Sequencing Market (by End User), $Billion, 2023-2033
  • Table 10: China Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 11: Japan Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 12: India Genome Sequencing Market, $Billion, 2023-2033
  • Table 13: India Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 14: Australia Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 15: South Korea Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 16: Rest-of-Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 17: Genome Sequencing Market, Key Development Analysis, January 2020-April 2024